Nock B[au] - Search Results

Year	Number of Results
1971	1
1976	4
1978	2
1979	2
1981	2
1983	1
1984	2
1985	4
1986	5
1987	2
1988	5
1989	7
1990	5
1991	2
1992	2
1993	3
1994	3
1995	2
1996	1
1997	2
1998	1
1999	2
2000	3
2001	1
2002	4
2003	3
2004	2
2005	7
2006	5
2007	2
2008	3
2009	1
2010	1
2011	3
2012	4
2013	5
2014	5
2015	4
2016	9
2017	8
2018	4
2019	6
2020	6
2021	2

1

Theranostic approaches in nuclear oncology: From bench to bed.

Nock BA, Maina T. Nock BA, et al. J Labelled Comp Radiopharm. 2019 Aug;62(10):612-614. doi: 10.1002/jlcr.3787. J Labelled Comp Radiopharm. 2019. PMID: 31325329 No abstract available.

2

Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.

Maina T, Nock BA, Kulkarni H, Singh A, Baum RP. Maina T, et al. Among authors: nock ba. PET Clin. 2017 Jul;12(3):297-309. doi: 10.1016/j.cpet.2017.02.007. Epub 2017 Apr 3. PET Clin. 2017. PMID: 28576168 Review.

3

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.

Kanellopoulos P, Kaloudi A, Jong M, Krenning EP, Nock BA, Maina T. Kanellopoulos P, et al. Among authors: nock ba. Pharmaceutics. 2020 Jun 9;12(6):528. doi: 10.3390/pharmaceutics12060528. Pharmaceutics. 2020. PMID: 32526874 Free PMC article.

4

In memoriam: Marion Hendriks-de Jong.

Krenning EP, Krestin GP, Bernsen MR, Dalm SU, Boerman OC, Elsinga PH, Glaudemans AWJM, Vugts DJ, Kunikowska J, Erba PA, Evangelista L, Nock BA, Maina T. Krenning EP, et al. Among authors: nock ba. Eur J Nucl Med Mol Imaging. 2021 Jul 5. doi: 10.1007/s00259-021-05463-4. Online ahead of print. Eur J Nucl Med Mol Imaging. 2021. PMID: 34223952 No abstract available.

5

[^99mTc]Tc-DGA1, a Promising CCK₂R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography.

Kaloudi A, Kanellopoulos P, Radolf T, Chepurny OG, Rouchota M, Loudos G, Andreae F, Holz GG, Nock BA, Maina T. Kaloudi A, et al. Among authors: nock ba. Mol Pharm. 2020 Aug 3;17(8):3116-3128. doi: 10.1021/acs.molpharmaceut.0c00605. Epub 2020 Jul 7. Mol Pharm. 2020. PMID: 32568549 Free PMC article.

6

[^99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.

Kanellopoulos P, Lymperis E, Kaloudi A, de Jong M, Krenning EP, Nock BA, Maina T. Kanellopoulos P, et al. Among authors: nock ba. Molecules. 2020 Jul 28;25(15):3418. doi: 10.3390/molecules25153418. Molecules. 2020. PMID: 32731473 Free PMC article.

7

Targeting prostate cancer with radiolabelled bombesins.

Maina T, Nock B, Mather S. Maina T, et al. Among authors: nock b. Cancer Imaging. 2006 Nov 8;6(1):153-7. doi: 10.1102/1470-7330.2006.0025. Cancer Imaging. 2006. PMID: 17098646 Free PMC article. Review.

8

Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach.

Barrett HE, Meester EJ, van Gaalen K, van der Heiden K, Krenning BJ, Beekman FJ, de Blois E, de Swart J, Verhagen HJ, Maina T, Nock BA, Norenberg JP, de Jong M, Gijsen FJH, Bernsen MR. Barrett HE, et al. Among authors: nock ba. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2856-2865. doi: 10.1007/s00259-020-04776-0. Epub 2020 Apr 15. Eur J Nucl Med Mol Imaging. 2020. PMID: 32291511 Free PMC article.

9

From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer.

Maina T, Nock BA. Maina T, et al. Among authors: nock ba. PET Clin. 2017 Apr;12(2):205-217. doi: 10.1016/j.cpet.2016.12.002. Epub 2017 Jan 31. PET Clin. 2017. PMID: 28267454 Review.

10

Optimizing the Profile of [^99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.

Kanellopoulos P, Nock BA, Krenning EP, Maina T. Kanellopoulos P, et al. Among authors: nock ba. Int J Mol Sci. 2020 Oct 26;21(21):7926. doi: 10.3390/ijms21217926. Int J Mol Sci. 2020. PMID: 33114537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results